Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Withdrawn × Hodgkin Disease × Clear all

Phase

Phase 2 13 Phase 1 10 Phase NA 6 Phase 1/2 3 Phase 3 1

Status

Completed 54 Unknown 10 Terminated 7 Active not recruiting 5 Recruiting 3 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Neoplasms 17 Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 10 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Pain 7 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Lymphoma, Follicular 5 Leukemia 5 Brain Neoplasms 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Carcinoma 4 Urogenital Neoplasms 3 Papillomavirus Infections 3 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Melanoma 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

ABVD protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01652261 2021-02-15

H11

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡